From professional translators, enterprises, web pages and freely available translation repositories.
msek
msec
Last Update: 2017-03-08
Usage Frequency: 8
Quality:
hos sjutton patienter ( 500 msek.
seventeen patients ( 500 msec.
Last Update: 2012-04-11
Usage Frequency: 2
Quality:
Warning: Contains invisible HTML formatting
ingen försöksperson hade ett qtcf >450 msek.
no subject had a qtcf >450 msec.
Last Update: 2017-04-26
Usage Frequency: 3
Quality:
Warning: Contains invisible HTML formatting
för ketoconazol 800 mg var ökningen 7. 0 msek.
the placebo-adjusted mean maximum increases in qtc from baseline after 800, 1200 and 1600 mg of voriconazole were 5.1, 4.8, and 8.2 msec, respectively and 7.0 msec for ketoconazole 800 mg.
Last Update: 2011-10-23
Usage Frequency: 1
Quality:
ingen patient hade ett maximalt qtcf ≥480 msek.
no patients had a maximum qtcf ≥480 msec.
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
ingen patient hade ett qtcf-värde om >480 msek.
no patient had a qtcf >480 msec.
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
Warning: Contains invisible HTML formatting
sjutton patienter ( 500 msek (se avsnitt 4. 4).
seventeen patients ( 500 msec (see section 4.4).
Last Update: 2011-10-23
Usage Frequency: 1
Quality:
Warning: Contains invisible HTML formatting
ingen patient erhöll ett intervall som överskred den eventuellt kliniskt relevanta tröskeln 500 msek.
no subject experienced an interval exceeding the potentially clinically relevant threshold of 500 msec.
Last Update: 2017-04-26
Usage Frequency: 4
Quality:
ett qtcf- värde överstigande 500 msek sågs hos < 1% av patienterna.
qtcf exceeding 500 msec was observed in < 1% of patients.
Last Update: 2012-04-11
Usage Frequency: 2
Quality:
Warning: Contains invisible HTML formatting
ingen patient i någon grupp erhöll en ökning av qtc som var ≥ 60 msek från baslinjen.
no subject in any group had an increase in qtc of ≥ 60 msec from baseline.
Last Update: 2017-04-26
Usage Frequency: 6
Quality:
ett qtcf- värde om > 500 msek sågs hos < 1% av dessa patienter.
qtcf of > 500 msec was observed in < 1% of these patients.
Last Update: 2012-04-11
Usage Frequency: 2
Quality:
Warning: Contains invisible HTML formatting
en ökning av qtcf om mer än 60 msek sågs hos <1 % av patienterna under behandling med studieläkemedlet.
qtcf increase from baseline exceeding 60 msec was observed in <1% of patients while on the study medicinal product.
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
Warning: Contains invisible HTML formatting
ingen patient erhöll ett intervall som överskred den potentiellt kliniskt relevanta tröskeln 500 msek (se avsnitt 5.1)
no subject experienced an interval exceeding the potentially clinically-relevant threshold of 500 msec (see section 5.1).
Last Update: 2017-04-26
Usage Frequency: 7
Quality:
högsta pr intervallet var 252 msek och inget andra eller tredje gradens hjärtblockad sågs (se avsnitt 4.4).
maximum pr interval was 252 msec and no second or third degree heart block was observed (see section 4.4).
Last Update: 2017-04-26
Usage Frequency: 3
Quality:
den inducerade förlängningen i qrs intervallet från 6 msek to 9,5 msek med högsta dosen lopinavir/ritonavir (800/200 mg två gånger dagligen) bidrar till qt- förlängningen.
the induced qrs interval prolongation from 6 ms to 9.5 ms with high dose lopinavir/ritonavir (800/200 mg twice daily) contributes to qt prolongation.
Last Update: 2017-04-26
Usage Frequency: 4
Quality: